France· FR:67284967
SITAGLIPTINE EVOLUGEN 100 mg, comprimé pelliculé
A sitagliptin product containing chlorhydrate de sitagliptine monohydraté, registered in France by EVOLUPHARM, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Sitagliptin is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BH01 (sitagliptin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Sitagliptin · ATC A10BH01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sitagliptin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.65 in France to $5.47 in Switzerland — a ×8.4 gap.
- France: $0.65 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Sitagliptin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.47
- IT Italy$1.78
- ES Spain$1.08
- FR France$0.65
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ
- Manufacturer
- EVOLUPHARM
- Country
- France (FR)
- ATC code
- A10BH01
- ATC class
- Sitagliptin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930250549plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)EUR 8.62
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
341 interactions on record for sitagliptin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sitagliptin · interactions on record
341 records
- 3 severe
- 292 moderate
- 44 minor
Most severe, free to view
- GatifloxacinJ01MA16severe
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10BH01
Sitagliptin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b16610c1-2e23-40d8-8642-158df207c091 GET /v1/drugs/b16610c1-2e23-40d8-8642-158df207c091?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67284967",
"date_amm": "2022-04-11",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.